Literature DB >> 20223009

Age and Geographical Distribution in Families with BRCA1/BRCA2 Mutations in the Slovak Republic.

Sona Ciernikova1, Miroslav Tomka, Michal Kovac, Viola Stevurkova, Vladimir Zajac.   

Abstract

Molecular diagnostics of hereditary breast and/or ovarian cancer is mainly based on detection of BRCA1 and BRCA2 germline mutations in suspected families. The aim of the study was to determine the frequency, age and geographical distribution in 130 Slovak hereditary breast and ovarian cancer (HBOC) families diagnosed within the years 2000-2004. Mutation screening was performed by single-strand conformation polymorphism (SSCP), heteroduplex analysis (HDA) and sequencing of PCR products showing an abnormal migration pattern. Twenty of 130 (15.6%) HBOC suspected families were found to carry mutations in BRCA1 or BRCA2 genes. The glossary data from the National Cancer Registry of Slovakia (NCRS) were compared with the results from HBOC suspected kindreds. Age distribution of breast cancer onset in our study group showed the highest proportion of onset in HBC families within the 5th decade of life, while NCRS reports at least a ten year later onset. These findings confirmed that cases of breast cancer under 50 years of age can be used as one of the principal criteria to assign a family as a hereditary breast and/or ovarian cancer kindred. In contrast with unselected ovarian cancer cases, about 75% of all HOC index cases were diagnosed between 40 and 49 years of age. To study the geographical distribution of hereditary breast and/or ovarian cancer, Slovakia was divided into three parts. The distribution of HBOC suspected families approximately follows this division, with an increasing number in the western area of the country.

Entities:  

Year:  2006        PMID: 20223009      PMCID: PMC3401926          DOI: 10.1186/1897-4287-4-1-7

Source DB:  PubMed          Journal:  Hered Cancer Clin Pract        ISSN: 1731-2302            Impact factor:   2.857


  12 in total

1.  Denaturing high-performance liquid chromatography detects reliably BRCA1 and BRCA2 mutations.

Authors:  T Wagner; D Stoppa-Lyonnet; E Fleischmann; D Muhr; S Pagès; T Sandberg; V Caux; R Moeslinger; G Langbauer; A Borg; P Oefner
Journal:  Genomics       Date:  1999-12-15       Impact factor: 5.736

Review 2.  Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility.

Authors:  M M de Jong; I M Nolte; G J te Meerman; W T A van der Graaf; J C Oosterwijk; J H Kleibeuker; M Schaapveld; E G E de Vries
Journal:  J Med Genet       Date:  2002-04       Impact factor: 6.318

3.  Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.

Authors:  A Antoniou; P D P Pharoah; S Narod; H A Risch; J E Eyfjord; J L Hopper; N Loman; H Olsson; O Johannsson; A Borg; B Pasini; P Radice; S Manoukian; D M Eccles; N Tang; E Olah; H Anton-Culver; E Warner; J Lubinski; J Gronwald; B Gorski; H Tulinius; S Thorlacius; H Eerola; H Nevanlinna; K Syrjäkoski; O-P Kallioniemi; D Thompson; C Evans; J Peto; F Lalloo; D G Evans; D F Easton
Journal:  Am J Hum Genet       Date:  2003-04-03       Impact factor: 11.025

4.  The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.

Authors:  J P Struewing; P Hartge; S Wacholder; S M Baker; M Berlin; M McAdams; M M Timmerman; L C Brody; M A Tucker
Journal:  N Engl J Med       Date:  1997-05-15       Impact factor: 91.245

5.  Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing.

Authors:  M A Unger; K L Nathanson; K Calzone; D Antin-Ozerkis; H A Shih; A M Martin; G M Lenoir; S Mazoyer; B L Weber
Journal:  Am J Hum Genet       Date:  2000-09-07       Impact factor: 11.025

6.  Genetic heterogeneity in hereditary breast cancer: role of BRCA1 and BRCA2.

Authors:  T R Rebbeck; F J Couch; J Kant; K Calzone; M DeShano; Y Peng; K Chen; J E Garber; B L Weber
Journal:  Am J Hum Genet       Date:  1996-09       Impact factor: 11.025

Review 7.  Genetics of breast cancer.

Authors:  M H Greene
Journal:  Mayo Clin Proc       Date:  1997-01       Impact factor: 7.616

Review 8.  Cancer susceptibility and the functions of BRCA1 and BRCA2.

Authors:  Ashok R Venkitaraman
Journal:  Cell       Date:  2002-01-25       Impact factor: 41.582

9.  The novel exon 11 mutation of BRCA1 gene in a high-risk family.

Authors:  S Cierniková; M Tomka; O Sedláková; M Reinerová; V Stevurková; M Kovác; M Cente; D Ilenciková; V Bella; V Zajac
Journal:  Neoplasma       Date:  2003       Impact factor: 2.575

Review 10.  The genetics of breast and ovarian cancer.

Authors:  D Ford; D F Easton
Journal:  Br J Cancer       Date:  1995-10       Impact factor: 7.640

View more
  1 in total

1.  Screening of BRCA1/2 genes mutations and copy number variations in patients with high risk for hereditary breast and ovarian cancer syndrome (HBOC).

Authors:  Fatima Zahra El Ansari; Farah Jouali; Nabila Marchoudi; Mohcine Mechita Bennani; Naima Nourouti Ghailani; Amina Barakat; Jamal Fekkak
Journal:  BMC Cancer       Date:  2020-08-10       Impact factor: 4.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.